Evidence map›Paper›PMID 29212219›Full record

ArticleOncotarget2017

MicroRNA-126a-5p enhances myocardial ischemia-reperfusion injury through suppressing Hspb8 expression.

Bimei Jiang, Yanjuan Liu, Pengfei Liang, Yuanbin Li, Zhenguo Liu, Zhongyi Tong, Qinglan Lv, Meidong Liu, Xianzhong Xiao

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Bimei JiangDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Yanjuan LiuDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Pengfei LiangDepartment of Burns and Plastic Surgery, Xiangya Hospital, Central South University, Changsha, P. R. China.
Yuanbin LiDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Zhenguo LiuDorothy M. Davis Heart and Lung Research Institute, Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Zhongyi TongDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Qinglan LvDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Meidong LiuDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Xianzhong XiaoDepartment of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, P. R. China.
Central South University · CNThe Ohio State University Wexner Medical Center · USXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we found several genes are involved in myocardial ischemia-reperfusion (M-I/R) injury. In this report, we first developed a mouse model of M-I/R injury and demonstrated microRNA-126a-5p was associated with the M-I/R injury by using high-throughput microRNA expression analysis. We further investigated the expression and function of microRNA-126a-5p during mouse M-I/R injury. We observed high expression of microRNA-126a-5p in the M-I/R mice and increased levels of LDH and CK-MB (damage markers) in the serum. H

Indexed as

H9C2 cellsHspb8ischemia-reperfusion injurymicroRNA-126a-5pmyocardium

Identifiers

PMID29212219
PMCPMC5706865
OpenAlexW2762508187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.